Absorption of phenytoin from rectal suppositories formulated with a polyethylene glycol base

Pharmacotherapy

Volumn 20, Issue 5, 2000, Pages 562-567

  Burstein, Aaron H ^a   Fisher, Karen M ^a   McPherson, M Lynn ^a   Roby, Carol A ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; PHENYTOIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; HUMAN; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, RECTAL; ANTICONVULSANTS; CROSS-OVER STUDIES; EXCIPIENTS; FEMALE; HUMANS; MALE; PHENYTOIN; PILOT PROJECTS; POLYETHYLENE GLYCOLS; STATISTICS, NONPARAMETRIC; SUPPOSITORIES;

EID: 0034024989     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.6.562.35157     Document Type: Article

References (7)

1. Fuerst RH, Graves NM, Kriel RL, Olson R. Absorption and safely of rectally administered phenytoin. Eur J Drug Metab Pharmacokinet 1988;13:257-60.
2. Meijer JWA, Kalff R. Less usual ways of administering antiepileptic drugs. In: Schneider H, Jnz D, Gardner-Thorpe C, et al, eds. Clinical pharmacology of anti-epileptic drugs. Berlin: Springer-Verlag, 1975:222-8.
3. Kvan L, Johannessen S. Lack of efficacy of phenytoin suppositories in antiepileptic treatment. Acta Neurol Scand 1976;54:103-4.
4. Moolenaar F, Jelsma RBH, Visser J, Meijer DKF. Manipulation of rectal absorption rate of phenytoin in man. Pharmaceut Weekblad Sci Ed 1981;3:1051-6.
5. Chang SW, da Silva JH, Kuhl DR. Absorption of rcctally administered phenytoin: a pilot study. Ann Pharmacother 1999;33:781-6.
6. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.
7. Jusko WJ, Koup JR, Alván G. Nonlinear assessment of phenytoin bioavailability. J Pharmacokinet Biopharm 1976;4:327-36.